Status:
UNKNOWN
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD)
Canadian Institutes of Health Research (CIHR)
Conditions:
Type2 Diabetes
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Fish oil contains a large amount of long-chain omega-3 polyunsaturated fatty acids, which are considered an important component of a healthy diet. As many patients do not eat fish, supplementation wit...
Detailed Description
Background: Cardiovascular disease (CVD) accounts for a large proportion of annual deaths around the world. In both the general population as well as in high-risk subgroups, achieving a healthy diet i...
Eligibility Criteria
Inclusion
- Randomized controlled trials
- Participants with diabetes
- Follow-up duration ≥ 52 weeks
- Intervention involves fish oil supplementation using supplements, supplemented foods, or dietary advice
- Control group
- Ascertainment of at least one cardiovascular outcome
Exclusion
- Non-randomized studies
- Participants without diabetes
- Follow-up duration \<52 weeks
- Multi-modal interventions
- Interventions of fish oils in the form of a prescription pharmaceutical drug (e.g. icosapent ethyl)
- Lack of a suitable control group (e.g. fish oil containing comparator)
- No viable cardiovascular outcome data.
Key Trial Info
Start Date :
March 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04327713
Start Date
March 28 2020
End Date
April 1 2021
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital
Toronto, Ontario, Canada, M5C 2T2